Â鶹´«Ã½¸ßÇå

In the News

• CervoMed Announces Positive Results from the Extension Phase of its Phase 2b Clinical Study of Neflamapimod in Patients with Dementia with Lewy Bodies,
• Why It's Hard for Patients to Get the Newest Alzheimer's Drugs,
• Dementia with Lewy Bodies Has Been Difficult to Diagnose Early, But Comprehensive Cognitive Testing Could Change That,
• Donepezil Found Effective for Improving Memory After Traumatic Brain Injury, 
• Cognition Therapeutics Announces Positive Results in Phase 2 Study of CT1812 in Dementia with Lewy Bodies,
• Who's Paying for Those Blood-based Biomarker Tests for Alzheimer's Disease?,
• Former DU Chancellor Rebecca Chopp reflects on living with Alzheimer’s, in 'Still Me',
• Alzheimer's and genetics: A complicated relationship,
• How rheumatoid arthritis and Down syndrome are helping researchers find treatments for Alzheimer’s,
• Clinical Trials hope to curb and reverse Alzheimer's 
• ‘Game of Thrones’ Study Offers Insights Into a Little-Understood Brain Disorder
• First patient at UCHealth receives new treatment for Alzheimer’s disease
• Alzheimer's Patients' Cognition Improves with Sargramostim (GM-CSF), New Study Shows. 
• Importance of White Matter by Dr. Christopher M. Filley. The Conversation, click here to read
• Interview with CUACC Expert on Aphasia. 
• Groundbreaking research could improve cognition for people with Down Syndrome.
• CU Anschutz Researchers Identify Drugs that Curb Alzheimer's Symptoms.

Clinical Trial Updates

• CervoMed Announces Positive Results from the Extension Phase of its Phase 2b Clinical Study of Neflamapimod in Patients with Dementia with Lewy Bodies,
• Cognition Therapeutics Announces Positive Results in Phase 2 Study of CT1812 in Dementia with Lewy Bodies -
  
• Donanemab (Kisunla) approved by FDA on July 2, 2024 - Clinic Statement Here
• Leqembi (lecanemab) approved by FDA and CMS - Clinic Statement Here
• Alzheimer's Patients' Cognition Improves with sargramostim (GM-CSF), New CUACC Study Shows - Press Release Here; 
• EIP Pharma Announces Positive Phase 2 Results for Neflamapimod in Mild-to-Moderate Dementia with Lewy bodies (DLB) - Press Release Here

University of Â鶹´«Ã½¸ßÇå Systemwide Land Acknowledgement

October 28, 2020

Office of the President

As we gather, we honor and acknowledge that the University of Â鶹´«Ã½¸ßÇå’s four campuses are on the traditional territories and ancestral homelands of the Cheyenne, Arapaho, Ute, Apache, Comanche, Kiowa, Lakota, Pueblo and Shoshone Nations. Further, we acknowledge the 48 contemporary tribal nations historically tied to the lands that comprise what is now called Â鶹´«Ã½¸ßÇå.

Acknowledging that we live in the homelands of Indigenous peoples recognizes the original stewards of these lands and their legacies. With this land acknowledgment, we celebrate the many contributions of Native peoples to the fields of medicine, mathematics, government and military service, arts, literature, engineering and more. We also recognize the sophisticated and intricate knowledge systems Indigenous peoples have developed in relationship to their lands.

We recognize and affirm the ties these nations have to their traditional homelands and the many Indigenous people who thrive in this place, alive and strong. We also acknowledge the painful history of ill treatment and forced removal that has had a profoundly negative impact on Native nations.

We respect the many diverse Indigenous peoples still connected to this land. We honor them and thank the indigenous ancestors of this place. The University of Â鶹´«Ã½¸ßÇå pledges to provide educational opportunities for Native students, faculty and staff and advance our mission to understand the history and contemporary lives of Native peoples.

See the full statement from the CU President .